Evidence supporting the use of: Alpha-lipoic acid
For the health condition: Nerve Damage

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Alpha-Lipoic Acid (ALA) is supported by scientific evidence for its use in the management of certain types of nerve damage, particularly diabetic neuropathy. Several randomized controlled trials and meta-analyses have investigated the efficacy of ALA in reducing symptoms associated with peripheral neuropathy, such as pain, paresthesia, and numbness. The proposed mechanism of action involves ALA’s potent antioxidant properties, which may help reduce oxidative stress implicated in nerve damage, especially in diabetes.

Clinical studies, including the ALADIN, SYDNEY, and NATHAN 1 trials, have demonstrated that intravenous administration of ALA (typically 600 mg/day) for 2-3 weeks can significantly improve neuropathic symptoms and deficits compared to placebo. Oral ALA has also shown benefit, though the effect size appears to be smaller and takes longer to manifest. Systematic reviews and meta-analyses have generally concluded that ALA is effective and safe as an adjunct therapy for diabetic neuropathy, though more data are needed on long-term outcomes and optimal dosing.

While ALA is sometimes used for other types of nerve damage, the strongest evidence exists for diabetic neuropathy. Its routine use outside of this context is not well-supported. Side effects are generally mild and include gastrointestinal symptoms. In summary, ALA’s use for nerve damage, especially diabetic neuropathy, is scientifically validated with moderate to strong evidence, primarily for short-term symptom relief.

More about alpha-lipoic acid
More about Nerve Damage

Products containing alpha-lipoic acid

We currently have no products on Vitabase that contain this ingredient.